Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ: PHAT · Real-Time Price · USD

12.56

-1.00 (-7.37%)

At close: Feb 27, 2026, 4:00 PM EST

13.00

+0.44 (3.50%)

After-hours: Feb 27, 2026, 5:36 PM EST

Phathom Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-221.25	-334.33	-201.59	-197.72	-143.88
Depreciation & Amortization	0.63	0.8	0.58	0.62	0.52
Other Amortization	3.01	2.19	1.88	2.11	3.6
Stock-Based Compensation	28.72	24.05	45.03	24.13	16.81
Other Operating Activities	34.48	55.82	30.18	18.89	1.81
Change in Accounts Receivable	-39.33	-37.16	-1.64	-	-
Change in Inventory	-11.78	-6.14	-9.44	-	-
Change in Accounts Payable	34.1	34.94	6.41	8.68	-9.79
Change in Other Net Operating Assets	4.63	-6.93	-8.98	-3.24	-17.52
Operating Cash Flow	-166.78	-266.77	-137.58	-146.53	-148.46
Capital Expenditures	-0.23	-0.14	-1.63	-1.04	-0.33
Investing Cash Flow	-0.23	-0.14	-1.63	-1.04	-0.33
Long-Term Debt Issued	-	59.4	211.99	95.45	96.89
Total Debt Issued	-	59.4	211.99	95.45	96.89
Long-Term Debt Repaid	-	-	-	-	-54.13
Net Debt Issued (Repaid)	-	59.4	211.99	95.45	42.76
Issuance of Common Stock	1.64	123.37	155.59	24.6	1.94
Repurchase of Common Stock	-1.93	-	-	-	-
Financing Cash Flow	-0.29	182.77	367.58	120.04	44.71
Net Cash Flow	-167.29	-84.13	228.37	-27.53	-104.08
Free Cash Flow	-167	-266.91	-139.21	-147.57	-148.79
Free Cash Flow Margin	-95.37%	-483.07%	-20412.61%	-	-
Free Cash Flow Per Share	-2.29	-4.22	-2.71	-3.77	-4.02
Cash Interest Paid	21.37	17.29	11.13	7.03	4.07
Levered Free Cash Flow	-107.86	-203.85	-90.45	-93.78	-96.73
Unlevered Free Cash Flow	-68.3	-161.04	-66.1	-78.83	-96.08
Change in Working Capital	-12.38	-15.3	-13.64	5.44	-27.32

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q